Author: Suzanne B. Robotti

A NIH task force is about to discuss best practices for pain management amid the nation’s opioid crisis. Meanwhile, the AMA wants pain removed as the “fifth vital sign.” What’s happening here? Pain is under attack. The AMA (American Medical Association) wants pain removed as the “fifth vital sign.” Doctors make initial assessments of health based on a list of vital signs: body temperature, pulse rate, respiration (breathing) rate and blood pressure. In the late 1990s pain was added to the list. The NIH (National Institutes of Health) has convened a task force to discuss pain management best practices. That…

Read More

A documentary filmmaker uses the death of his brother, a WWE star, as the starting point to look at the hows and whys of opioid addiction. I’m not a big documentary fan, but I was drawn in by the title “Prescription Thugs” (released in theaters January 22, 2016 and now available on many pay-per-view platforms). This is a very personal first-person documentary on painkiller medicine addiction by filmmaker Chris Bell. “Prescription Thugs” is a follow up to his first documentary, “Bigger, Faster, Stronger” (2008) in which he explored the use of steroids. In “Prescription Thugs,” Bell uses his brother’s death due to his…

Read More

It’s discouraging to see that doctors continue to prescribe opioids in the face of rising addiction, overdoses and valid alternatives Shockingly, the CDC has proposed guidelines for PCPs (primary care providers) on prescribing opioids — OxyContin, Percocet, Vicodin and the like — for chronic pain. What’s the problem with that? Everything. Why are PCPs — family physicians or internists — not referring patients with chronic pain to a specialist who is trained in pain management including the use of NSAIDS, opioids and alternatives to drugs? Why are opioids being prescribed for chronic pain when there is very little evidence that…

Read More

Is is safe? Is it effective? Those are the 2 major questions that the FDA asks. Without a “yes” for both, the FDA won’t approve that use for a drug. On March 10, 2016, it was announced that Amarin’s suit against the FDA has been settled and both have agreed to live with the previous federal court ruling. That ruling was that the FDA could not prohibit Amarin’s truthful promotion of a drug for off-label (unapproved) uses because doing so would violate the protection of free speech. Is this a win for our First Amendment? Not in my opinion. I…

Read More

It’s in my nature — I see danger everywhere. But it would help if it wasn’t true that there is danger everywhere! Even in the OTC aisle of the drug store. OTC drugs are supposed to be broadly safe, hard to abuse and unlikely to cause harm or addiction if you follow the instructions. But many people don’t follow the instructions, and even those who do can make mistakes leading to big problems. Acetaminophen (Tylenol and generics) is a drug that is too easy to overdose on, even when following instructions. The FDA limits acetaminophen to 4,000 mg in 24 hours. If you use Extra…

Read More
FDA

Following are some wonderfully interesting articles on issues in health care. We did not report on them earlier because MedShadow Foundation’s mission is to gather and share information on the side and long term effects of prescription drugs and these articles study the system of medicine. However, I can’t bear to not share these ideas. One Drug, Two Names, Many Problems, OpEd, New York Times, Dec. 1, 2013 This is an “Of course!” article, first published in the NYT blog, Opinionator, but I found it when published as an OpEd piece. The writer, Theresa Brown, states a problem that I…

Read More

“Are there any substantial studies that focus on the side effects of long-term use of SSRI antidepressants?” This was the question posed recently in the New York Times “Ask Well” column.  Everybody should be asking their doctor, their friends and their legislators why this is the response: “The short answer is no. But your question gets to the heart of an important problem that we have in this country: that all medications are approved by the FDA on the basis of relatively short-term studies, even though many are used long-term for medical and psychiatric disorders that are chronic, if not…

Read More